Lipohypertrophy
Links shared publicly online about this topic
Forum on Nutrition and Exercise: Treatment for Lipohypertrophy
thebody.com — “Forum on Nutrition and Exercise: Treatment for Lipohypertrophy” View full resource at thebody.com
Most Recently Shared on October 13, 2010 at 5:02 pm By:
Ask the HIV/AIDS Experts: "What Do You Know About Treatments for Lipohypertrophy?" http://bit.ly/dez4Dj #fat
A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy) - The Body
thebody.com — “A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy) - The Body” View full resource at thebody.com
Most Recently Shared on November 11, 2010 at 4:09 pm By:
Take a closer look at Egrifta, newly approved treatment for HIV-associated belly fat: how it works, who should take it. http://bit.ly/do6cvJ
Lipodystrophy, HIV: eMedicine Dermatology
emedicine.medscape.com — “Overview: HIV-associated lipodystrophy is a syndrome that occurs in individuals with HIV infection who are being treated with antiretroviral medications. Although the term HIV-associated lipodystrophy refers to abnormal central fat accumulation (lipohypertrophy) and localized loss of fat ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 19, 2010 at 6:18 pm By:
HIV patients may experience fat accumulation or fat loss from localized portions of the body. Learn why this happens. http://bit.ly/9EJaDJ
Surgery Article | HIV
mdlinx.com — “Open Neck Lipectomy for Patients with HIV-Related Cervical Lipohypertrophy” View full resource at mdlinx.com
Most Recently Shared on April 13, 2011 at 11:34 am By:
#plasticsurgery Open Neck Lipectomy for Patients with HIV-Related Cervical Lipohypertrophy: Aesthetic Plastic Surgery http://bit.ly/eDSYif
FDA Approves Egrifta (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy
drugs.com — “Egrifta (tesamorelin) is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Includes Egrifta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 12, 2010 at 12:10 am By:
FDA Approves Egrifta (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abd... http://bit.ly/aGIPwA #drug
FDA Approves Egrifta (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy
drugs.com — “Egrifta (tesamorelin) is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Includes Egrifta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 12, 2010 at 1:25 am By:
FDA Approves Egrifta for the Reduction of Excess Abdominal Fat in HIV Patients with Lipodystrophy - http://bit.ly/bYTUCU
FDA Approves EGRIFTA™ (tesamorelin For Injection): First And Only Treatment For The Reduction Of Excess Abdominal Fat In HIV-infected Patients
medicalnewstoday.com — “EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced that the U.S. Food and Drug Administration (FDA) has approved EGRIFTA™ (tesamorelin for injection) as the first an” View full resource at medicalnewstoday.com
Most Recently Shared on November 12, 2010 at 7:05 pm By:
FDA Approves EGRIFTA™ (tesamorelin For Injection): First And Only Treatment For The Reduction Of Excess Abdomina... http://mnt.to/3Mvz
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
The Body
The Complete HIV/AIDS Resource.
-
The Body
The Complete HIV/AIDS Resource.
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
Advertisement

